Expression of the Endothelin axis in bladder cancer: Relationship to clinicopathologic parameters and long-term survival

European Urology

Volumn 47, Issue 5, 2005, Pages 593-600

  Wülfing, Christian ^a   Eltze, Elke ^a   Yamini, Johann ^a   Wülfing, Pia ^a   Bierer, Stefan ^a   Böcker, Werner ^a   Hertle, Lothar ^a   Semjonow, Axel ^a   Sievert, Karl Dietrich ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bladder neoplasms; Endothelins; Immunohistochemistry; Prognosis; Receptors

Indexed keywords

ENDOTHELIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 17144364661     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.12.019     Document Type: Article

References (34)

1. American Cancer Society: Cancer Statistics 2004. www.cancer.org.
2. G. Prout, and V.F. Marshall The prognosis with untreated bladder tumors Cancer 9 1956 551 558
3. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
4. J. Nelson, A. Bagnato, B. Battistini, and P. Nisen The endothelin axis: emerging role in cancer Nat Rev Cancer 3 2003 110 116
5. H. Ali, M. Dashwood, K. Dawas, M. Loizidou, F. Savage, and I. Taylor Endothelin receptor expression in colorectal cancer J Cardiovasc Pharmacol 36 2000 S69 S71
6. J.R. Wu-Wong, W.J. Chiou, R. Dickinson, and T.J. Opgenorth Endothelin attenuates apoptosis in human smooth muscle cells Biochem J 328 1997 733 737
7. A. Bagnato, and F. Spinella Emerging role of endothelin-1 in tumor angiogenesis Trends Endocrinol Metab 14 2003 44 50
8. G.M. Rubanyi, and M.A. Polokoff Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology Pharmacol Rev 46 1994 325 415
9. D. Salani, V. Di Castro, M.R. Nicotra, L. Rosano, R. Tecce, and A. Venuti Role of endothelin-1 in neovascularization of ovarian carcinoma Am J Pathol 157 2000 1537 1547
10. E.L. Bek, and M.A. McMillen Endothelins are angiogenic J Cardiovasc Pharmacol 36 2000 S135 S139
11. F. Spinella, L. Rosano, V. Di Castro, P.G. Natali, and A. Bagnato Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells J Biol Chem 277 2002 27850
12. P. Wülfing, R. Diallo, C. Kersting, C. Wülfing, C. Poremba, and R.R. Greb Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease Oncol Rep 11 2004 791
13. J.B. Nelson, S.P. Hedican, D.J. George, A.H. Reddi, S. Piantadosi, and M.A. Eisenberger Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate Nat Med 1 1995 944 949
14. M.A. Carducci, R.J. Padley, J. Breul, N.J. Vogelzang, B.A. Zonnenberg, and D.D. Daliani Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial J Clin Oncol 21 2003 679 689
15. A. Bagnato, D. Salani, V. Di Castro, J.R. Wu-Wong, R. Tecce, and M.R. Nicotra Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth Cancer Res 59 1999 720 727
16. D. Salani, L. Rosano, V. Di Castro, F. Spinella, A. Venuti, and R.J. Padley ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro Clin Sci (Lond) 103 Suppl 48 2002 318S
17. A. Bagnato, A. Cirilli, D. Salani, P. Simeone, A. Muller, and M.R. Nicotra Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade Cancer Res 62 2002 6381 6384
18. P. Wülfing, R. Diallo, C. Kersting, C. Wülfing, C. Poremba, and A. Rody Expression of endothelin-1, endothelin-a, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up Clin Cancer Res 9 2003 4125 4131
19. C. Wülfing, E. Eltze, Piechota Hj, H. Abol-Enein, P. Wülfing, M.E. Bode, L. Hertle, and K.D. Sievert Expression of endothelin-1and endothelin-A and -B receptors in invasive bladder cancer Oncol Reports 13 2005 223 228
20. C. Wülfing, E. Eltze, D. von Struensee, P. Wülfing, L. Hertle, and H. Piechota Cyclooxygenase-2 expression in bladder cancer: correlation with poor outcome after chemotherapy Eur Urol 45 2004 46 52
21. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
22. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Chancer Chemother Rep 50 1966 163 170
23. J.P. Stein, G. Lieskovsky, R. Cote, S. Groshen, A.C. Feng, and S. Boyd Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
24. A. Venuti, D. Salani, V. Manni, F. Poggiali, and A. Bagnato Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy FASEB J 14 2000 2277 2283
25. K. Alanen, D.X. Deng, and S. Chakrabarti Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma Histopathology 36 2000 161 167
26. E. Asham, A. Shankar, M. Loizidou, S. Fredericks, K. Miller, and P.B. Boulos Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism Br J Cancer 85 2001 1759 1763
27. S.I. Ahmed, J. Thompson, J.M. Coulson, and P.J. Woll Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium Am J Respir Cell Mol Biol 22 2000 422 431
28. A. Demunter, C. De Wolf-Peeters, H. Degreef, M. Stas, and J.J. van den Oord Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma Virchows Arch 438 2001 485 491
29. R. Lahav, and G. Heffner Patterson PH: An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo Proc Natl Acad Sci USA 96 1999 11496
30. M.M. Pao, M. Tsutsumi, G. Liang, E. Uzvolgyi, F.A. Gonzales, and P.A. Jones The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells Hum Mol Genet 10 2001 903 910
31. B.A. Usmani, B. Harden, N.J. Maitland, and A.J. Turner Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines Clin Sci (Lond) 103 Suppl 48 2002 314S
32. B. Arun, G. Kilic, R. Ashfaq, H.M. Saboorian, and T. Gokaslan Endothelin converting enzyme-1 expression in endometrial adenocarcinomas Cancer Invest 19 2001 779
33. T.T. Zou, F.M. Selaru, Y. Xu, V. Shustova, J. Yin, and Y. Mori Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon Oncogene 21 2002 4855
34. A. Bagnato, L. Rosano, F. Spinella, V. Di Castro, R. Tecce, and P.G. Natali Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression Cancer Res 64 2004 1436